MUCORMYCOSIS ASSOCIATED WITH COVID-19: LITERATURE REVIEW

Authors

  • Licoa-Navarro Yosenka Jaritza Estudiante de la Escuela de Medicina de la Universidad Técnica de Manabí. Departamento de Ciencias Médicas. Facultad Ciencias de la Salud. UTM. https://orcid.org/0000-0002-3059-4220
  • Anzules-Guerra Jazmín Beatriz Departamento de Especialidades Médicas. Facultad Ciencias de la Salud. Universidad Técnica de Manabí. UTM. Portoviejo, Ecuador. https://orcid.org/0000-0002-2789-5831
  • Milian-Hernández Josue Departamento de Especialidades Médicas. Facultad Ciencias de la Salud. Universidad Técnica de Manabí. UTM. Portoviejo, Ecuador. https://orcid.org/0000-0001-6157-9202

Keywords:

COVID-19, Mucormycosis, coinfection, mucomorals, SARS Virus

Abstract

Introduction: The coronavirus-19 pandemic is a viral infection, which has been advanced to be associated with opportunistic conditions. Among these stands out mucormycosis or also known as "black fungus disease", so named due to the invasion of endothelial cells, thrombosis and tissue necrosis. Objective: was to describe the relevant findings in relation to the, diagnosis and treatment of mucormycosis associated with COVID-19. Methodology is based on secondary research by reviewing literature extracted from databases such as: PubMed, Medline, LILACS, IBECS, Cochrane, Scopus, SciELO, without language restriction, using MESH keywords. Discussion: The most common types of mucormycosis in the context of COVID-19 were rhino-orbit-cerebral, and pulmonary, although there are also other less common types such as cutaneous, gastrointestinal, renal and disseminated. Conclusion: The association between COVID-19 and mucormycosis, due to the presence of various risk factors such as poorly controlled type 2 diabetes mellitus and immunosuppression, the clinical spectrum of these entities is non-specific, which makes it difficult to diagnose early, given this it is important to multimodal management that prevents delay the start of antifungal treatment.

Keywords: COVID-19, Mucormycosis, coinfection, mucomorals, SARS Virus.

Downloads

Download data is not yet available.

References

Accinelli, R. A., Zhang-Xu, C. M., Ju-Wang, J. D., Yachachin-Chávez, J. M., Cáceres-Pizarro, J. A., B., T.-B. K., . . . Paiva-Andrade, A. (2020). COVID-19: la pandemia por el nuevo virus SARS-CoV-2. Rev Peru Med Exp Salud Pública, 37(2).

Al-Tawfiq, J. A., Alhumaid, S., Alshukairi, A. N., Temsah, M. H., Barry, M., Al Mutair, A., . . . Dhama, K. (2021). COVID-19 and mucormycosis superinfection: the perfect storm. Infection, 49(5), 833-853. https://doi.org/10.1007/s15010-021-01670-1

Ambrosioni, J., Bouchuiguir-Wafa, K., & Garbino, J. (2010). Emerging invasive zygomycosis in a tertiary care center: epidemiology and associated risk factors. Int J Infect Dis, 14 Suppl 3, e100-103. https://doi.org/10.1016/j.ijid.2009.11.024

Arana, C., Cuevas Ramírez, R. E., Xipell, M., Casals, J., Moreno, A., Herrera, S., . . . Esforzado, N. (2021). Mucormycosis associated with COVID-19 in two kidney transplant patients. Transpl Infect Dis, 23(4), e13652. https://doi.org/10.1111/tid.13652

Aranjani, J. M., Manuel, A., Abdul Razack, H. I., & Mathew, S. T. (2021). COVID-19-associated mucormycosis: Evidence-based critical review of an emerging infection burden during the pandemic's second wave in India. PLoS Negl Trop Dis, 15(11), e0009921. https://doi.org/10.1371/journal.pntd.0009921

Azhar, A., Khan, W. H., Khan, P. A., Alhosaini, K., Owais, M., & Ahmad, A. (2022). Mucormycosis and COVID-19 pandemic: Clinical and diagnostic approach. J Infect Public Health, 15(4), 466-479. https://doi.org/10.1016/j.jiph.2022.02.007

Bitar, D., Van Cauteren, D., Lanternier, F., Dannaoui, E., Che, D., Dromer, F., . . . Lortholary, O. (2009). Increasing incidence of zygomycosis (mucormycosis), France, 1997-2006. Emerg Infect Dis, 15(9), 1395-1401. https://doi.org/10.3201/eid1509.090334

Chao, C. M., Lai, C. C., & Yu, W. L. (2022). COVID-19 associated mucormycosis - An emerging threat. J Microbiol Immunol Infect, 55(2), 183-190. https://doi.org/10.1016/j.jmii.2021.12.007

Choudhary, G. R., Aggarwal, A., Jain, V., & Jena, R. (2021). COVID-19 and fatal renal mucormycosis: Contributory or coincidental? Indian J Urol, 37(3), 270-273. https://doi.org/10.4103/iju.iju_197_21

Guinea, J., Escribano, P., Vena, A., Muñoz, P., Martínez-Jiménez, M. D. C., Padilla, B., & Bouza, E. (2017). Increasing incidence of mucormycosis in a large Spanish hospital from 2007 to 2015: Epidemiology and microbiological characterization of the isolates. PLoS One, 12(6), e0179136. https://doi.org/10.1371/journal.pone.0179136

Hassan, M. I. A., & Voigt, K. (2019). Pathogenicity patterns of mucormycosis: epidemiology, interaction with immune cells and virulence factors. Med Mycol, 57(Supplement_2), S245-S256. https://doi.org/10.1093/mmy/myz011

Helmy, Y. A., Fawzy, M., Elaswad, A., Sobieh, A., Kenney, S. P., & Shehata, A. A. (2020). The COVID-19 Pandemic: A Comprehensive Review of Taxonomy, Genetics, Epidemiology, Diagnosis, Treatment, and Control. J Clin Med, 9(4). https://doi.org/10.3390/jcm9041225

Hussain, S., Baxi, H., Riad, A., Klugarová, J., Pokorná, A., Slezáková, S., . . . Klugar, M. (2021). COVID-19-Associated Mucormycosis (CAM): An Updated Evidence Mapping. Int J Environ Res Public Health, 18(19). https://doi.org/10.3390/ijerph181910340

Hussain, S., Riad, A., Singh, A., Klugarová, J., Antony, B., Banna, H., & Klugar, M. (2021). Global Prevalence of COVID-19-Associated Mucormycosis (CAM): Living Systematic Review and Meta-Analysis. J Fungi (Basel), 7(11). https://doi.org/10.3390/jof7110985

Iglesias-Osores, S., & Rodriguez-Perla, H. (2020). Características Microbiológicas de Mucor sp. Revista Experiencia en Medicina del Hospital Regional Lambayeque, 6(1).

Iqbal, N., Irfan, M., Jabeen, K., Kazmi, M. M., & Tariq, M. U. (2017). Chronic pulmonary mucormycosis: an emerging fungal infection in diabetes mellitus. J Thorac Dis, 9(2), E121-E125. https://doi.org/10.21037/jtd.2017.02.31

Iñiguez-García, M. A., del Villar-Trujillo, A., Cardona-Infante, V., Carrillo-Ponce, C., & Téllez-Becerra, J. L. (2016). Diagnóstico y tratamiento de la mucormicosis pulmonar: reporte de un caso. Rev Fac Med Univ Nac Auton Mex, 59(2).

Jeong, W., Keighley, C., Wolfe, R., Lee, W. L., Slavin, M. A., Kong, D. C. M., & Chen, S. C. (2019). The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports. Clin Microbiol Infect, 25(1), 26-34. https://doi.org/10.1016/j.cmi.2018.07.011

Kurien, A. A., Srinivasaprasad, N. D., & Valavan, K. T. (2022). Renal infarction due to COVID-19-associated renal mucormycosis. Kidney Int, 101(3), 655. https://doi.org/10.1016/j.kint.2021.07.027

Mahalaxmi, I., Jayaramayya, K., Venkatesan, D., Subramaniam, M. D., Renu, K., Vijayakumar, P., . . . Vellingiri, B. (2021). Mucormycosis: An opportunistic pathogen during COVID-19. Environ Res, 201, 111643. https://doi.org/10.1016/j.envres.2021.111643

Martín-Gómez, M. T., & Salavert-Lletí, M. (2021). Mucormicosis: perspectiva de manejo actual y de futuro. Rev Iberoam Micol, 38, 91-100.

Nagalli, S., & Kikkeri, N. S. (2021). Mucormycosis in COVID-19: A systematic review of literature. Infez Med, 29(4), 504-512. https://doi.org/10.53854/liim-2904-2

Nayak, N., Khan, E., & Panigrahi, D. (2022). COVID-19 and Mucormycosis Coinfection: How Challenging It Is. Can J Infect Dis Med Microbiol, 2022, 8617212. https://doi.org/10.1155/2022/8617212

Paraskevis, D., Kostaki, E. G., Magiorkinis, G., Panayiotakopoulos, G., Sourvinos, G., & Tsiodras, S. (2020). Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event. Infect Genet Evol, 79, 104212. https://doi.org/10.1016/j.meegid.2020.104212

Patel, A., Agarwal, R., Rudramurthy, S. M., Shevkani, M., Xess, I., Sharma, R., . . . Network3, M. (2021). Multicenter Epidemiologic Study of Coronavirus Disease-Associated Mucormycosis, India. Emerg Infect Dis, 27(9), 2349-2359. https://doi.org/10.3201/eid2709.210934

Prakash, H., & Chakrabarti, A. (2019). Global Epidemiology of Mucormycosis. J Fungi (Basel), 5(1). https://doi.org/10.3390/jof5010026

Ray, S. K., & Mukherjee, S. (2021). COVID-19-Associated Mucormycosis, A New Incident in Recent Time: Is An Emerging Disease in The Near Future Impending? Avicenna J Med, 11(4), 210-216. https://doi.org/10.1055/s-0041-1735383

Ren, L. L., Wang, Y. M., Wu, Z. Q., Xiang, Z. C., Guo, L., Xu, T., . . . Wang, J. W. (2020). Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study. Chin Med J (Engl), 133(9), 1015-1024. https://doi.org/10.1097/CM9.0000000000000722

Revankar, S. (2021). Mucormicosis (cigomicosis).

Rudramurthy, S. M., Hoenigl, M., Meis, J. F., Cornely, O. A., Muthu, V., Gangneux, J. P., . . . ISHAM, E. a. (2021). ECMM/ISHAM recommendations for clinical management of COVID-19 associated mucormycosis in low- and middle-income countries. Mycoses, 64(9), 1028-1037. https://doi.org/10.1111/myc.13335

Ruiz Camps, I., & Salavert Lletí, M. (2018). [The treatment of mucormycosis (zygomycosis) in the 21st century]. Rev Iberoam Micol, 35(4), 217-221. https://doi.org/10.1016/j.riam.2018.09.001

Salud, O. P. d. l., & Salud, O. M. d. l. (2021). Alerta Epidemiológica: Mucormicosis asociada a COVID-19. In. Washington D.C.: OPS/OMS.

Sen, M., Honavar, S. G., Bansal, R., Sengupta, S., Rao, R., Kim, U., . . . Group, m. o. t. C. O.-I. S. o. M. i. C.-C. S. (2021). Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India - Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1. Indian J Ophthalmol, 69(7), 1670-1692. https://doi.org/10.4103/ijo.IJO_1565_21

Singh, A. K., Singh, R., Joshi, S. R., & Misra, A. (2021). Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India. Diabetes Metab Syndr, 15(4), 102146. https://doi.org/10.1016/j.dsx.2021.05.019

Skiada, A., Lass-Floerl, C., Klimko, N., Ibrahim, A., Roilides, E., & Petrikkos, G. (2018). Challenges in the diagnosis and treatment of mucormycosis. Med Mycol, 56(suppl_1), 93-101. https://doi.org/10.1093/mmy/myx101

Sánchez, A. J., Aparicio, K., Miranda, C. E., Castillo, C. R., & Arellano, N. B. (2021). COVID-19: epidemiología, virología y transmisibilidad. Revista Eugenio Espejo, 15(3), 89-99.

Wei, L. W., Zhu, P. Q., Chen, X. Q., & Yu, J. (2022). Mucormycosis in Mainland China: A Systematic Review of Case Reports. Mycopathologia, 187(1), 1-14. https://doi.org/10.1007/s11046-021-00607-4

Published

2022-08-11

How to Cite

Licoa-Navarro, Y. J., Anzules-Guerra, J. B., & Milian-Hernández, J. (2022). MUCORMYCOSIS ASSOCIATED WITH COVID-19: LITERATURE REVIEW. GESTAR Arbitrated Scientific Journal in Health Research. ISSN: 2737-6273., 5(10 Ed. esp.), 22-39. Retrieved from https://www.journalgestar.org/index.php/gestar/article/view/76

Issue

Vol. 5 No. 10 Ed. esp. (2022): Revista Científica Arbitrada en Investigaciones de la Salud GESTAR (Edición especial agosto 2022)

Section

Articles

Copyright (c) 2022 GESTAR Arbitrated Scientific Journal in Health Research. ISSN: 2737-6273.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.